Skip to main content
. Author manuscript; available in PMC: 2014 Jul 16.
Published in final edited form as: Histopathology. 2013 May 15;63(1):74–82. doi: 10.1111/his.12140

Table 4.

Association between SHP2 expression and breast cancer intrinsic subtype

Intrinsic subtype SHP2-positive SHP2-negative p-value
(n) (%) (n) (%) 0.9108
Luminal A
(ER+ and/or PR+, HER2, Ki-67 < 14%)
98 45.2 119 54.8
Luminal B (HER2-negative)
ER+ and/or PR+, HER2, Ki-67 ≥ 14%)
307 44.9 376 55.1
Luminal B (HER2-positive)
(ER+ and/or PR+, HER2+)
74 47.9 82 52.6
HER2 type (ER, PR, HER2+) 59 53.1 52 46.8
Basal-like (ER, PR, HER2) 110 48.5 117 51.5